Moneycontrol Presented by Motilal Oswal
Days hours minutes
Nerolac
Presented by :

Co-Presenting Sponsor :

Capital Trade

Powered by :

Godrej Properties

Associate Sponsors :

Aegon Life
LIC Housing Finance
Indiabulls
DHFL

Co-Presenting Sponsor

Capital Trade

Associate Sponsors

  • Indiabulls
  • Aegon Life
  • LIC Housing Finance
  • DHFL
SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > UTI Mutual Fund > UTI Pharma & Healthcare Fund (D)

UTI Pharma & Healthcare Fund (D)

PLAN: Regular OPTIONS: Dividend
70.730 0.54 (0.77%)

NAV as on 22 Jan, 2018

CRISIL MF RANK

Not Ranked

Riskometer

HIGH

HIGH

  • Principal at high risk.
FUND FAMILY : UTI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
ranking by CRISIL

Not Ranked

This scheme is not ranked by CRISIL (for quarter ended Sep 2017) since it does not fulfill certain eligibility criteria of CRISIL

View Top ranked funds in other categories

Close UTI Pharma & Healthcare Fund - Income Option Newly introduced w.e.f August 01, 2005.
Benchmark Index:
 
View Historic Graph From     To     

Returns (NAV as on 22 Jan, 2018)

Period Returns (%) Rank #
1 mth 2.6 4
3 mth 7.7 4
6 mth 5.3 4
1 year 6.1 5
2 year 1.5 4
3 year 1.3 6
5 year 14.5 6

# Moneycontrol Rank within 8 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2017 4.3 -6.5 -2.6 10.3 5.8
2016 -9.0 4.1 3.2 -10.0 -9.9
2015 17.8 -7.5 6.0 -6.4 12.5
2014 0.9 12.6 24.0 2.4 43.2
2013 -4.1 10.0 5.5 8.3 23.0

View where it stands within its peers

* Returns over 1 year are Annualised

* Calculation Remark - Dividends are reinvested at the rate of return

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns 2.6 7.7 5.3 6.1 1.5 1.3 14.5
Category avg 2.9 6.4 2.8 4.3 -0.5 2.2 11.9
Difference of Fund returns and Category returns -0.3 1.3 2.5 1.8 2.0 -0.9 2.6
Best of category 3.7 9.7 9.0 11.5 4.1 4.9 18.5
Worst of category 1.0 4.3 1.6 0.9 -3.3 1.3 14.5
Benchmark returns # 3.5 1.2 -3.3 -5.5 -6.9 -5.7 10.3
Difference of Fund returns and Benchmark returns -0.9 6.5 8.6 11.6 8.4 7.0 4.2
# Benchmark Index: NIFTY PHARMA

Investment Info

Investment Objective

Investment will be made in stocks of companies engaged in manufacturing of Pharmaceuticals bulk drugs, formulations & OTC drugs, medical equipment and accessories, personal healthcare products and also companies owning/managing hospitals etc.

Scheme details

Fund Type Open-Ended
Investment Plan Dividend
Launch date Jun 26, 1999
Benchmark NIFTY PHARMA
Asset Size (Rs cr) 329.03 (Dec-31-2017)
Minimum Investment Rs.5000
Last Dividend Rs.1.70 (Oct-28-2010) View Dividend History
Bonus N.A.
Fund Manager Ritesh Rathod / V Srivatsa
View performance of schemes managed by the Fund Manager
Notes UTI Pharma & Healthcare Fund - Income Option Newly introduced w.e.f August 01, 2005.

Load Details

Entry Load N.A
Exit Load 1.00%
Load Comments Exit Load 1% if redeemed within 1 Year from the date of allotment.

Contact Details

Regd. Office UTI Tower, Gn Block, Bandra-Kurla Complex, Bandra (E), Mumbai, 400051
Tel. No. 66786666
Fax No. 26524921
Email uti@giasbm01.vsnl.net.in
Website http://www.utimf.com

Peer Comparison

Sector - Pharma & Healthcare Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Reliance Pharma Fund (G) Not Ranked
1,536.22 9.4 8.5 10.5 4.0 16.5
SBI Pharma Fund (G) Not Ranked
860.04 4.3 1.6 0.9 2.1 17.5
UTI Pharma & Health (G) Not Ranked
329.03 7.7 5.3 6.1 1.3 14.5
Reliance Pharma Fund - Direct (G) Not Ranked
215.62 9.7 9.0 11.5 4.9 17.5
SBI Pharma Fund - Direct (G) Not Ranked
214.61 4.6 2.3 2.1 3.4 18.5
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (Dec 29, 17)

Equity Sector Value
(Rs cr)
Asset %
Cipla Pharmaceuticals 25.40 7.72
Torrent Pharma Pharmaceuticals 25.30 7.69
Alkem Lab Pharmaceuticals 22.44 6.82
Aurobindo Pharm Pharmaceuticals 21.88 6.65
Sun Pharma Pharmaceuticals 21.85 6.64
Pfizer Pharmaceuticals 20.47 6.22
Ajanta Pharma Pharmaceuticals 18.92 5.75
Strides Shasun Pharmaceuticals 18.59 5.65
Divis Labs Pharmaceuticals 14.15 4.30
Sanofi India Pharmaceuticals 13.42 4.08

Full Portfolio

Sector Allocation (Dec 29, 17)

Sector %

1-Year

HighLow

Pharmaceuticals 88.19 92.01 92.01
Services 4.59 4.01 4.01
Miscellaneous 3.97 2.22 2.22
Manufacturing 2.39 0.00 0.00

View All Sectors

Asset Allocation (%)(Dec 29, 17)

Equity 99.14
Others 0.00
Debt 0.05
Mutual Funds N.A
Money Market 0.00
Cash / Call 0.79

View All

Concentration

Holdings (%)
Top 5 35.52
Top 10 61.52
Sector (%)
Top 3 96.75

News & Videos

News

Messages & Community

Sections
Follow us on
Available On